New patent for Astrazeneca Ab drug QTERN

Annual Drug Patent Expirations for QTERN Qtern is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twelve patents…

The post New patent for Astrazeneca Ab drug QTERN appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Do NOT follow this link or you will be banned from the site!